GLP-1 Peptides Explained: What They Are & How They Work
GLP-1 medicines are one of the most talked-about treatment categories in Australia, especially around diabetes, appetite and weight management. This guide explains what GLP-1 receptor agonists are, how they work in simple terms, and why prescription access and counterfeit-product warnings matter.
Quick Summary
GLP-1 receptor agonists are prescription-only medicines in Australia that act on a hormone pathway involved in blood sugar, appetite signalling and digestion. Current Australian examples include semaglutide, liraglutide, dulaglutide and tirzepatide. The TGA has warned consumers about counterfeit and unregistered GLP-1 products promoted online, including products that claimed to contain GLP-1 but contained no GLP-1 or GLP-1 analogues. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-weight-loss-products-claiming-contain-glp-1?utm_source=chatgpt.com))
Important: This page is educational only. Peptide Hub Australia does not sell GLP-1 medicines, peptides, prescriptions or injectable products. GLP-1 receptor agonists are prescription-only medicines in Australia and should only be used under medical supervision. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-weight-loss-products-claiming-contain-glp-1?utm_source=chatgpt.com))
What is GLP-1?
GLP-1 stands for glucagon-like peptide-1. It is a hormone produced naturally in the body, mainly in response to eating.
GLP-1 helps the body coordinate several signals linked to blood glucose, insulin release, appetite and digestion. Medicines called GLP-1 receptor agonists are designed to mimic or activate this pathway for specific medical uses.
- GLP-1 is a natural hormone pathway.
- GLP-1 medicines are prescription medicines.
- They are not normal supplements or casual wellness products.
- Medical assessment matters because they affect important metabolic systems.
How do GLP-1 medicines work?
GLP-1 receptor agonists work by activating GLP-1 receptors. In plain English, they help amplify signals that are already part of normal appetite and blood sugar regulation.
Different GLP-1 medicines have different dosing schedules, indications and product information, but they are commonly discussed around three key effects: insulin signalling, appetite signalling and slower stomach emptying.
- They can increase insulin response when glucose is elevated.
- They can reduce glucagon signalling in some contexts.
- They can affect appetite and fullness signals.
- They can slow gastric emptying, especially early in treatment.
Plain English: GLP-1 medicines do not simply “burn fat.” They work through appetite, glucose and digestion-related pathways. That is why they need proper medical screening, dosing guidance and monitoring.
GLP-1 medicines currently discussed in Australia
The TGA lists GLP-1 receptor agonist class medicines marketed in Australia, including Ozempic, Wegovy, Saxenda, Trulicity and Mounjaro. These are prescription medicines used in type 2 diabetes and/or obesity contexts depending on the product. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/product-warnings-updated-glp-1-ra-class?utm_source=chatgpt.com))
| Medicine / Compound | Class | Australian Context |
|---|---|---|
| Semaglutide Ozempic, Wegovy |
GLP-1 receptor agonist | Prescription medicine Used in different clinical contexts depending on product and medical suitability. |
| Liraglutide Saxenda, Victoza |
GLP-1 receptor agonist | Prescription medicine Associated with diabetes and/or weight-management treatment contexts depending on product. |
| Dulaglutide Trulicity |
GLP-1 receptor agonist | Prescription medicine Commonly associated with type 2 diabetes treatment. |
| Tirzepatide Mounjaro |
Dual GIP/GLP-1 receptor agonist | Prescription medicine Acts on both GIP and GLP-1 pathways and is used in approved clinical contexts. |
| Retatrutide | Investigational triple agonist | Investigational Not the same as an approved consumer GLP-1 medicine. |
| Online “GLP-1 peptide” products | Unregistered / unclear | High risk May be counterfeit, mislabelled, unapproved or contain no GLP-1 analogue. |
Blood sugar signalling
GLP-1 medicines can help influence insulin and glucagon signalling in a glucose-dependent way. This is why the class is important in type 2 diabetes treatment.
Appetite and fullness
GLP-1 pathways also interact with appetite and satiety signals. This is one reason some GLP-1 medicines are used in chronic weight-management contexts.
Gastric emptying
GLP-1 medicines can slow stomach emptying, particularly around treatment initiation and dose changes. This effect can be relevant to side effects and medicine interactions.
Medical monitoring
Because GLP-1 medicines affect important metabolic and digestive systems, they should be used with proper medical assessment, prescription guidance and follow-up.
Counterfeit warning: The TGA has warned Australians not to buy unregistered GLP-1 products from social media or digital platforms. TGA testing found some imported products labelled as GLP-1 contained no GLP-1 or GLP-1 analogues. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-weight-loss-products-claiming-contain-glp-1?utm_source=chatgpt.com))
GLP-1 treatment starts with medical advice
GLP-1 medicines should be discussed with a qualified healthcare professional. For broader peptide supplier education, Peptide Hub Australia compares transparency signals, reviews and package audits.
Safer signs
- Assessment by a qualified healthcare professional.
- Valid prescription where clinically appropriate.
- Dispensing through a legitimate Australian pharmacy.
- Clear product name, dose and patient information.
- Follow-up monitoring for side effects and suitability.
Red flags
- “No prescription needed” GLP-1 claims.
- Social media, Telegram or marketplace sellers.
- Research vials marketed as weight-loss injections.
- Products claiming to be cheap Ozempic, Wegovy or Mounjaro alternatives.
- Before-and-after marketing replacing medical advice.
FAQ: GLP-1 Peptides Explained
What does GLP-1 stand for?
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite, glucose and digestion-related signalling.
Are GLP-1 medicines prescription-only in Australia?
Yes. The TGA states GLP-1 receptor agonists such as semaglutide, tirzepatide and liraglutide are prescription-only medicines in Australia and should only be used under medical supervision. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-weight-loss-products-claiming-contain-glp-1?utm_source=chatgpt.com))
Is semaglutide a GLP-1 medicine?
Yes. Semaglutide is a GLP-1 receptor agonist and is the active ingredient in products such as Ozempic and Wegovy.
Is tirzepatide a GLP-1 medicine?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. It acts on both GIP and GLP-1 pathways and is associated with Mounjaro.
Do GLP-1 medicines just burn fat?
No. GLP-1 medicines work through appetite, blood sugar and digestion-related pathways. They are medical treatments, not fat-burning supplements.
Can I buy GLP-1 peptides online?
You should not buy prescription GLP-1 medicines from unverified online sellers, social media or marketplaces. The TGA advises consumers to only buy prescription medicines from a local registered pharmacy. ([tga.gov.au](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-weight-loss-products-claiming-contain-glp-1?utm_source=chatgpt.com))
Does Peptide Hub Australia sell GLP-1 medicines?
No. Peptide Hub Australia does not sell GLP-1 medicines, peptides, prescriptions or injectable products.
Related Guides
Continue researching with these Peptide Hub Australia pages.
Disclaimer: This page is for general educational purposes only. Peptide Hub Australia does not provide medical advice, diagnosis, treatment recommendations, prescribing guidance or buying instructions. Peptide Hub Australia does not sell GLP-1 medicines, peptides, prescriptions or injectable products. Always speak with a qualified healthcare professional before making medical decisions.